CryoPort, Inc. - Common Stock (NQ:CYRX)

19.10 +3.05 (+19.00%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CryoPort, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 12, 2023

Via Benzinga

Looking Into CryoPort's Return On Invested Capital ↗

May 17, 2023

Via Benzinga

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

CryoPort: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity? ↗

April 10, 2023

The global biotechnology industry was worth $859 billion in 2022, and it is predicted to reach $1.6 trillion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% over the forecast period.

Via Benzinga

Expert Ratings for CryoPort ↗

December 08, 2022

Via Benzinga

5 Analysts Have This to Say About CryoPort ↗

December 08, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About CryoPort ↗

December 08, 2022

Via Benzinga

Expert Ratings for CryoPort ↗

November 16, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About CryoPort ↗

November 16, 2022

Via Benzinga

Cryoport: Temperature-Controlled Supply Chain Solutions Provider Sees Almost 30% Bump In Revenues ↗

April 03, 2023

Robert Stefanovich, CFO of Cryoport, Inc. (NASDAQ: CYRX), was recently a guest on Benzinga’s All-Access.

Via Benzinga

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

March 08, 2023

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

Via News Direct

Topics Economy

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

March 08, 2023

By David Willey, Benzinga

Via TheNewswire.com

Topics Economy

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds? ↗

March 07, 2023

Cryoport Inc. (NASDAQ: CYRX) provides the life sciences industry with comprehensive supply chain solutions to support vital therapeutics.

Via Benzinga

Stocks Extend Slump, Head For Weekly Losses ↗

February 24, 2023

Stocks are extending their premarket losses, with the Dow Jones Industrial Average down 409 points.

Via Talk Markets

Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday ↗

February 24, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Toll Brothers To Rally 25%? Here Are 10 Other Analyst Forecasts For Friday ↗

February 24, 2023

Oppenheimer boosted the price target for Universal Display Corporation (NASDAQ: OLED) from $150 to $160. Oppenheimer analyst Martin Yang maintained an Outperform rating on the stock. Universal Display...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 24, 2023

Via Benzinga

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

Amazon, Apple, Tesla And Other Big Gainers From Thursday ↗

November 11, 2022

U.S. stocks closed higher on Thursday, with the Dow Jones jumping more than 1,200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Yelp, Twilio, Atlassian, And Other Big Losers From Friday ↗

November 07, 2022

U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session ↗

November 04, 2022

Gainers

Via Benzinga

Whither Small Caps After Fed’s Tough Talk? ↗

August 29, 2022

For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and...

Via Talk Markets

CryoPort Earnings Perspective: Return On Capital Employed ↗

August 23, 2022

According to Benzinga Pro data, during Q2, CryoPort (NASDAQ:CYRX) posted sales of $64.15 million. Earnings were up 31.54%, but CryoPort still reported an overall loss of $9.18 million.

Via Benzinga

Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗

August 15, 2022

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...

Via Talk Markets

Cryoport Stock Shows Market Leadership With Jump To 91 RS Rating ↗

August 08, 2022

On Monday, Cryoport stock hit a key technical milestone, with its Relative Strength Rating upgraded to 91, a rise from 82 the day before.

Via Investor's Business Daily

Recap: CryoPort Q2 Earnings ↗

August 04, 2022

CryoPort (NASDAQ:CYRX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings CryoPort missed estimated earnings...

Via Benzinga

CryoPort's Earnings: A Preview ↗

August 03, 2022

CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.